Objective. An acute gout attack is often misdiagnosed as cellulitis. Differentiating these two diseases is crucial when deciding treatment strategies. Delta neutrophil index (DNI) represents the difference between leucocyte subfractions that corresponds to the fraction of immature granulocytes and can predict the bacterial infection burden. The aim of this study was to evaluate the potential of DNI as a predictive marker for differentiating an acute gout attack and cellulitis.
Introduction
Gouty arthritis is the most common inflammatory arthritis, which is characterized by acute and severe pain, resulting from the deposition of MSU crystals in joints [1] . In a majority of patients, an acute gout attack usually provokes inflammatory signs in joints classically involving periarticular tissues, mimicking the signs of cellulitis [2] . Particularly in the very early phase, the clinical similarity often makes it difficult to discriminate an acute gout attack from cellulitis. For these reasons, making a precise diagnosis is crucial for determining the correct treatment strategies, which will prevent not only the misuse of antibiotics for an acute gout attack, but also the delay of antibiotic initiation for cellulitis.
Considering the pathophysiology of gout, hyperuricaemia is a favourable clue for acute gout attack rather than cellulitis. However, its clinical application has limitations in that normouricaemia can be observed in one-third of acute gout attack cases [3] , and a considerable number of people having hyperuricaemia are free from symptoms of gout [4] . Furthermore, acute phase reactants, such as ESR and CRP, are non-specifically elevated in both diseases. Procalcitonin, which has been used as a marker for bacterial infection to guide antibiotic use [5, 6] , is an alternative clue. However, procalcitonin also has limitations in that it may be significantly elevated in patients with an acute gout attack, especially those with tophi, and has positive correlations with pain, severity, ESR and CRP in these individuals [7] . Therefore, a novel complementary serum marker showing a significant difference between the two diseases might contribute to the differential diagnosis.
Immature granulocytes (IGs) in peripheral blood reflect the enhanced production of granulocytes in bone marrow as a result of infection [8, 9] , and it has been proved that elevated IGs in peripheral blood are a useful marker for predicting infection and sepsis [10, 11] . The delta neutrophil index (DNI) is a novel index of the circulating fraction of IGs, and it is automatically calculated by a cell analyser, not by manual counting [12] . So far, previous studies have demonstrated the importance of DNI as a predictor for infection and sepsis; a higher DNI was associated with disseminated intravascular coagulation, bacteraemia and mortality in sepsis patients, and it was correlated with disease severity in sepsis patients [12, 13] . As DNI is associated with bacterial infections, we previously reported the usefulness of DNI in differentiating between flare and infection in febrile SLE patients [14] . In this study, we investigated whether DNI contributes to the differential diagnosis between an acute gout attack and cellulitis in the crucial early phase.
Methods

Patients and data collection
We collected the data of 328 patients with an acute gout attack and 451 patients with cellulitis, who had been admitted to Yonsei University Health System, Severance Hospital, from January 2010 to April 2015. We used the clinical data retrieval system and reviewed their medical records. This study was approved by the institutional review board of Yonsei University, College of Medicine (Ref. 4-2015-0949) . Written consent was waived by the institutional review board because this study was performed retrospectively and data were analysed anonymously. We finally enrolled 184 patients with an acute gout attack and 183 patients with cellulitis in this study according to the following inclusion criteria: patients who presented with symptoms of either acute gout attack or cellulitis confined to the lower extremities below the thigh; patients who had all laboratory tests on our short clinical research form performed within 24 h after hospitalization and before antibiotic administration; patients who had been diagnosed with an acute gout attack according to the 1977 ACR classification criteria for the acute arthritis of primary gout [15] and recovered without antibiotic administration or patients who had been diagnosed with cellulitis without insidious infections other than bacterial infection (in order to minimize the confounding factors) who recovered after receiving antibiotics; and patients who were >18 years of age. We excluded 412 patients, as follows: 193 patients concomitantly had other infections, such as osteomyelitis, necrotizing fasciitis, skin abscess or septic arthritis; 81 did not fulfil the 1977 ACR classification criteria; 46 patients received antibiotics or anti-gout drugs prior to laboratory tests; 40 patients had received both antibiotics and anti-gout drugs; 37 patients had concurrent haematological diseases or malignancies or had received GM-CSF or chemotherapy; 12 patients had infection by virus, fungus or Mycobacterium; and 3 patients were pregnant (supplementary Fig. S1 , available at Rheumatology Online). Symptom duration was defined as the period from the onset of symptoms to the laboratory tests. We reviewed the results of culture studies for bacterial infection in specimens from blood, wound, synovial or soft-tissue fluid, or any other body fluid where infection had been strongly suspected. Additionally, we referred to the results of radiological tests, if needed to confirm the diagnosis. Epidemiological and laboratory data were collected as described in Table 1 .
Subgroup analysis
We reclassified the 184 patients with an acute gout attack into two subgroups according to the presence of MSU confirmation and compared them further with those with cellulitis; 112 of 184 (60.9%) patients were classified as patients with an acute gout attack without MSU confirmation, meaning that aspiration of synovial or soft-tissue fluid had not been performed. Furthermore, we compared patients with an acute gout attack and cellulitis having normal serum uric acid concentrations to ensure that DNI was a differential marker. Seventy-four of 184 (40.2%) patients were classified as patients with an acute normouricaemic gout attack, and 138 of 183 (75.4%) patients were classified as patients with normouricaemic cellulitis. Normouricaemia was defined as a serum uric acid concentration <7.0 mg/dl [16] .
DNI measurement
A specific type of automatic cell analyser (ADVIA 2120; Healthcare Diagnostics, Forchheim, Germany) was used to determine DNI, as described in our previous study [12] . This cell analyser has two independent channels to analyse white blood cell (WBC) count, a cytochemical MPO channel and a lobularity nuclear density channel. DNI is the difference between the two leucocyte differentials, which is calculated by using MPO reaction and light beam reflection from the nuclear lobularity channel [17] . DNI is calculated automatically by subtracting the fraction of mature polymorphonuclear leucocytes from the sum of MPO-reactive cells and is reported as a part of the routine complete blood count in our institute.
Statistical analysis
All statistical analyses were performed using IBM SPSS software, version 20.0 (Armonk, New York, USA). Continuous variables are expressed as means (S.D.), and categorical variables are presented as absolute and relative counts. Group differences were assessed using unpaired t-test for continuous variables, whereas the 2 test or Fisher's exact test was used for categorical data. Optimal cut-offs of variables with significant differences between the two groups (WBC count, DNI, ESR, CRP, uric acid and procalcitonin) for predicting cellulitis were extrapolated by calculating the area under the receiver operator characteristic (AUROC) curve as per each comparison test. We selected each cut-off to maximize the sum of sensitivity and specificity. The multivariate logistic regression model was used to find the independent predictive value for cellulitis among the variables that had statistical differences in univariate analysis or clinical implications. Values of P < 0.05 were considered significant.
Results
Comparison of variables between patients with an acute gout attack and those with cellulitis MSU crystals were confirmed in 72 of 184 (39.1%) patients with an acute gout attack, whereas bacterial infection was identified in 45 of 183 (24.5%) patients with cellulitis. Patients with an acute gout attack were older and there was a lower proportion of females compared with those with cellulitis. Patients with cellulitis had higher mean WBC counts and CRP but lower mean ESR and uric acid concentrations than those with an acute gout attack (P < 0.01 for all). The mean DNI in patients with cellulitis was significantly elevated compared with that in patients with an acute gout attack (2.8 vs 0.6%; P < 0.001), and the mean procalcitonin concentration showed a similar pattern (5.2 vs 1.0 ng/ml; P = 0.045; Table 1 ). In addition, to evaluate the influence of positive culture study (bacterial burden) on DNI, we also reclassified the patients with cellulitis into the following three subgroups: cellulitis with negative wound culture results (n = 138); cellulitis with positive wound culture without bacteraemia (n = 35); and cellulitis with bacteraemia (n = 10). Patients with an acute gout attack exhibited a lower mean DNI than those in all subgroups of cellulitis. DNI was increased along with the bacterial burden among the subgroups of cellulitis (0.6% for acute gout attack vs 2.6% for cellulitis with negative wound culture results vs 2.8% for cellulitis with positive wound culture vs 6.2% for cellulitis with bacteraemia; P < 0.001; supplementary Fig. S2 , available at Rheumatology Online).
Optimal cut-offs of variables and multivariate analysis in patients with an acute gout attack and those with cellulitis
We determined the optimal cut-offs of variables having significant differences between the two diseases for predicting cellulitis using the AUROC as follows: WBC [16] .
In multivariate logistic regression analysis of the statistically significant variables, we found that DNI 5 1.7% was the only independent factor for predicting cellulitis after adjusting for age and sex [odds ratio (OR) = 9.699, 95% CI: 2.335, 40.290; P = 0.002; Table 2 ].
Comparison of patients with an acute gout attack without MSU confirmation and those with cellulitis
Patients with cellulitis showed higher mean WBC counts and CRP than those with an acute gout attack without MSU confirmation (P < 0.005 for both), but there were no significant differences in ESR or procalcitonin between the two groups, unlike results including all study subjects. Instead, patients with an acute gout attack without MSU confirmation had higher mean uric acid than those with cellulitis (7.2 vs 5.7 mg/dl; P < 0.001). The mean DNI in patients with cellulitis was also significantly higher compared with that in patients with an acute gout attack without MSU confirmation (2.8 vs 0.5%; P < 0.001; Table 3 ). We determined the optimal cut-offs of variables having significant differences between the two diseases for predicting cellulitis using AUROC as follows: WBC 5 11 800/ mm 3 (AUC = 0.639, 95% CI: 0.576, 0.702); DNI 5 1.4%
(AUC = 0.763, 95% CI: 0.709, 0.816); and CRP 5 123.0 mg/l (AUC = 0.606, 95% CI: 0.540, 0.671). Again, we set 7.0 mg/dl as the cut-off value for uric acid. In multivariate logistic regression analysis between the statistically and clinically significant variables, we found that DNI 5 1.4% was the only independent factor for predicting cellulitis after adjusting for age and sex (OR = 18.763, 95% CI: 1.852, 190.120; P = 0.013; Table 4 ).
Comparison of variables between patients with an acute normouricaemic gout attack and those with normouriacemic cellulitis
The proportion of female sex in patients with an acute gout attack was much lower than in patients with cellulitis. Patients with cellulitis had higher mean WBC counts and CRP but lower mean uric acid than patients with an acute gout attack in normouricaemic patients (P < 0.05 for all). In this analysis, there were no significant differences in ESR or procalcitonin between the two groups. The mean DNI in patients with normouricaemic cellulitis was higher than in patients with an acute normouricaemic gout attack (2.6 vs 0.7%; P < 0.001; Table 5 ). We determined optimal cut-offs of variables having significant differences between the two diseases for predicting cellulitis using AUROC as follows: WBC 5 In multivariate logistic regression analysis of the statistically significant variables, we found that DNI 5 1.7% was the only independent factor for predicting cellulitis after adjusting for age and sex (OR = 5.215, 95% CI: 1.092, 24.896; P = 0.038; Table 6 ).
Discussion
To date, a single marker for differentiating an acute gout attack from cellulitis has not been reported. Acute phase reactants such as ESR, CRP or procalcitonin have been considered, but no proper cut-off for clinical discrimination between the two diseases has been determined, and their values fluctuate substantially. In addition, procalcitonin has been suggested as a marker for bacterial infection [18] , but its usefulness in differentiating between the two diseases in clinical settings remains controversial [7] . In the present study, we demonstrated the usefulness of DNI for differential diagnosis between an acute gout attack and cellulitis at a crucial time to determine the proper treatment strategies. Despite a reasonable understanding of the pathogenesis and the availability of effective treatment of gout, its accurate diagnosis is often issue of debate, especially when the patient presents with severe soft tissue swelling. DNI >1.7% was an independent predictive value for cellulitis rather than an acute gout attack. Identifying the possibility of infection in a patient who is suspected of an acute gout attack is the most important step to prevent septic complications compared with a relatively harmless gout attack, and DNI gives us valuable information that can be applied in clinical practice.
This study has important implications for clinicians in that the burden of gout is gradually increasing, and quick, accurate diagnosis is crucial for reducing the use of antibiotics, thereby minimizing the antibiotic resistance.
Subgroup analysis of patients without MSU confirmation consistently showed that DNI was an independent predictive marker for cellulitis. This may be of great significance, because MSU crystal confirmation using bipolarizing microscopy cannot be performed in all patients suspected of an acute gout attack. Moreover, aspiration of joint fluids may provoke unwanted complications in patients taking anticoagulants or having a possibility of cellulitis. However, DNI can be calculated easily in a routine complete blood count test within 2 h. Our results revealed no difference in DNI between patients with an acute gout attack with and without MSU confirmation (0.7 ± 1.0 vs 0.5 ± 0.9%; P = 0.166; data not shown). It is a great benefit in practice that DNI results are given promptly without arthrocentesis, which is crucial for making quick decisions, especially in emergency departments. Additionally, when we compared the differences in DNI among normouricaemic patients, we found a similar pattern to that of bacterial burden. This result might reinforce the role of DNI as a differentiating marker between an acute gout attack and cellulitis. Making a differential diagnosis in normouricaemic patients is more challenging, because hyperuricaemia is an important clue in diagnosing gout despite its limitations. In this study, we demonstrated that a DNI >1.7% can indicate cellulitis rather than an acute gout attack.
In healthy individuals, polymorphonuclear neutrophil granulocytes undergo several stages, from progenitor cells to mature granulocytes in the bone marrow, and then migrate into peripheral blood. The presence of IGs in the peripheral blood represents an activated bone marrow response to infection [19] . An automated cell analyser easily provides an index of the fraction of IGs reported as DNI. DNI is closely related to sepsis severity, detection rate by blood cultures, disseminated intravascular coagulation scores and mortality [12, 13] . These findings suggest that DNI increases as the burden of infection becomes heavier. The present study also showed similar findings that DNI was higher when inflammation was related to infection, and patients with bacteraemia showed markedly increased DNI, as high as 6.2%, similar to previous studies [14, 20, 21] .
The mechanism that differentiates DNI between an acute gout attack and cellulitis is unclear. However, we assume that it is related to the natural course of an acute gout attack, which resolves spontaneously even without treatment. In the serial analysis of the SF of an acute gout attack, there are increased concentrations of some antiinflammatory cytokines, such as TGF-b1 and IL-1 receptor antagonist, which inactivate inflammation [22, 23] . In contrast, inflammation in cellulitis that is caused by infection does not resolve spontaneously until the infection is controlled. Therefore, bone marrow might be continuously activated in cellulitis, resulting in increased DNI.
There are several limitations to our study. First, it was an uncontrolled retrospective study at a single centre. Second, we checked DNI only once, on the first day of hospitalization; hence, serial alteration of DNI over time is unclear. Third, the measurement of DNI is limited to the specific type of cell analyser. Future studies will be needed to overcome these limitations and to clarify more information to enable DNI to be used precisely in clinical settings.
In conclusion, the present study demonstrates that DNI >1.7% was an independent predictive marker for cellulitis in patients who are suspected of an acute gout attack. We suggest keeping in mind the possibility of cellulitis by www.rheumatology.oxfordjournals.org priority when DNI is elevated in patients whose diagnosis is uncertain for an acute gout attack. However, as our study was carried out retrospectively, further prospective analyses with larger populations will reinforce our research. 
